In its 2021 ESG Report, Moderna outlines its corporate responsibility strategy and defines five guiding focus areas for ongoing and future efforts: Medicines for patients Employees Environment Community Governance and ethics The report also includes updates to the progress Moderna has made to date: 25% of total doses of its COVID-19 vaccine in 2021 were delivered to low- and middle-income countries. 40% of Moderna’s U.S. workforce identifies as racially or ethnically diverse, up from 35% in 2020. Moderna announced its Global Public Health Strategy to: Advance vaccines targeting 15 pathogens…
Read MoreImpacting Human Health: Moderna’s 2021 ESG Report
